NFNevin Fazlıoğlu

Nevin Fazlıoğlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nevin Fazlıoğlu has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism

    by Aysun Şengül, Yusuf Aydemir, Derya Kızılgöz Özaydın, Pınar Akın Kabalak, Yasemin Söyler, Hüsnü Baykal, Muzaffer Onur Turan, Ersin Alkılınç, Fulsen Bozkuş, Pınar Yıldız Gülhan, et al.

    Aims: To evaluate the clinical characteristics, radiological findings, and mortality-related factors in patients with COVID-19-associated pulmonary embolism (PE). Methods: This multicenter retrospective cohort study analyzed data from 13 tertiary centers and included adult patients with molecularly confirmed SARS-CoV-2 infection and radiologically verified PE. Results: A total of 112 patients were included (mean age: 59.9±14.1 years), of whom 50% had severe pneumonia. PE and COVID-19 were diagnosed simultaneously in 29.5% of cases. The median interval between COVID-19 diagnosis and PE development was 6 days. Despite standard or intermediate-dose thromboprophylaxis, PE occurred in 42.9% of patients. Computed tomography pulmonary angiography demonstrated predominantly peripheral embolic involvement (58.0%). According to early mortality risk stratification, 5.4% of patients were classified as high risk and 19.6% as intermediate-high risk. The in-hospital and 30-day mortality rates were 7.1% and 12.5%, respectively. Mortality was significantly associated with advanced age, comorbidities, severe pneumonia, thrombocytopenia, elevated lactate dehydrogenase and ferritin levels, high/intermediate-high risk classification, intensive care unit admission, and invasive mechanical ventilation. Multivariate logistic regression identified thrombocytopenia as an independent predictor of 30-day mortality (OR 10.11, 95% CI 1.49-68.92; p=0.01). Conclusion: PE commonly develops during the early phase of COVID-19 and may occur despite thromboprophylaxis. Early recognition and individualized, risk-adapted anticoagulation strategies are essential.

  • Open Access

    Associations of Systemic Immune-Inflammation Index and Hematological Markers with Symptom Burden and Radiological Stage in Sarcoidosis

    by Ezgi Erdem Türe, Berna Akıncı Özyürek, Fulsen Bozkuş, Nilgün Yilmaz Demirci, Celal Satıcı, Ayshan Mammadova, Gözde Kalbaran Kismet, Zeynep Erayman Ozen, Onur Yazıcı, Şule Taş Gülen, et al.

    Background/Objectives: Sarcoidosis is a multisystem inflammatory disease characterized by heterogeneous clinical manifestations and variable disease severity. Hematological inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), red cell distribution width (RDW), and systemic immune-inflammation index (SII), have recently attracted attention as accessible indicators of systemic inflammation in sarcoidosis. This study aimed to evaluate radiological stage, symptom burden, pulmonary function parameters, and hematological markers in patients with sarcoidosis. Methods: This retrospective multicenter cohort study included histopathologically confirmed sarcoidosis patients from 10 centers. Demographic characteristics, clinical manifestations, pulmonary function test parameters, serum angiotensin-converting enzyme (ACE) levels, and hematological inflammatory markers (MPV, RDW, NLR, PLR, SII) were evaluated. Patients were categorized according to radiological stage (stage 0–I vs. stage II–IV), symptomatic status, and symptom burden (<3 vs. ≥3 symptoms). Results: Among 458 patients included in the study, stage I (47.8%) and stage II (46.9%) disease were the predominant radiological presentations. Patients with stage II–IV disease were older and demonstrated significantly lower forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and diffusing capacity for carbon monoxide (DLCO) values together with higher serum ACE levels compared with stage 0–I disease. Dyspnea, weight loss, and extrapulmonary involvement were more frequent in stage 2–4 disease. No significant associations were observed between radiological stage and NLR, PLR, or SII values. MPV and RDW values differed significantly between symptomatic and asymptomatic patients. Patients with ≥3 symptoms demonstrated significantly lower pulmonary function parameters together with statistically significant higher NLR, PLR, and SII values. In multivariate analyses, only the SII demonstrated an independent association with a high symptom burden. Conclusions: Serum ACE levels were associated with advanced radiological stage, whereas hemogram-derived inflammatory indices, particularly the NLR, PLR, and SII, were associated with symptom burden rather than radiological stage in sarcoidosis and may reflect symptomatic inflammatory activity.

  • Open Access

    SCUBE-1 Levels and Their Relationship with Endothelial Dysfunction in Obstructive Sleep Apnea Syndrome Patients

    by Nevin Fazlıoğlu, Cihan Aydın, Aykut Demirkıran, Demet Özkaramanlı Gür, Ahsen Yılmaz, Aliye Çelikkol

    Objective: Obstructive sleep apnea syndrome (OSAS) increases the risk of vascular dysfunction by causing hypoxemia due to recurrent obstructions in the upper airway. This can put pressure on the vasculature and impair endothelial function. SCUBE-1 gains importance in OSAS as a biomarker that may reflect this dysfunction. We focused in this study on the association between levels of SCUBE-1 and endothelial dysfunction in patients suffering from OSAS. Methods: A study population of 75 individuals participated in the study. Participants were categorized as normal (n=18), mild OSAS (n=22), moderate OSAS (n=19) and severe OSAS (n=16) according to polysomnography findings. Evaluation parameters included SCUBE-1 levels, polysomnography measurements, flow-mediated dilatation (FMD), carotid intima-media thickness (CIMT), and comprehensive laboratory analyses. Results: SCUBE-1 levels were significantly higher in the severe OSAS group (15.8 ± 4.2 ng/mL, p< 0.001). SCUBE-1 showed a moderate negative correlation with FMD (r = − 0.248, p < 0.001) and a significant negative correlation with CIMT (r = − 0.512, p < 0.001). ROC analysis demonstrated good diagnostic accuracy (AUC: 0.871, 95% CI: 0.797– 0.945) for SCUBE-1 in identifying severe OSAS. Conclusion: OSAS severity correlates with the rise in SCUBE-1 levels, and this biomarker may serve as an important attribute in profiling endothelial dysfunction. SCUBE-1 can indeed be an effective biomarker to identify subtle changes in the vascular biology of OSAS patients and aid early interventions.


  • Open Access

    Prognostic value of the CALLY index in idiopathic pulmonary fibrosis: Association with acute exacerbations and mortality

    by Nevin Fazlıoğlu, Ahsen Yılmaz, Ezgi Pınar Küçük, Mithat Fazlıoğlu, Levent Cem Mutlu

    BACKGROUND AND AIM: The CRP-albumin-lymphocyte (CALLY) index, which combines C-reactive protein (CRP), albumin, and lymphocyte values, serves as a predictive tool for patients with cancer and inflammatory diseases. However, the CALLY index has not been evaluated for its application in idiopathic pulmonary fibrosis (IPF). This study examined the relationship between CALLY scores and acute exacerbations, mortality, and lung function assessment results in patients with IPF. METHODS: A total of 129 IPF patients diagnosed between January 2020 and December 2023 were studied by reviewing demographic information, test results, and pulmonary function assessments. Patients were enrolled from both outpatient and inpatient services at a single tertiary center. The CALLY index was calculated using the formula: albumin (g/dL) / [CRP (mg/dL) × NLR], with NLR representing the neutrophil-to-lymphocyte ratio. Data on acute exacerbations of IPF (AE-IPF) and all-cause mortality were obtained from longitudinal follow-up records. Participants received follow-up care for a median of 36 months (range: 6-48 months). RESULTS: Of the 129 patients analyzed, 30 (23.3%) died and 10 (7.8%) experienced AE-IPF during follow-up. The CALLY index was significantly lower in patients with AE-IPF compared to those without (1.41±1.58 vs. 3.48±3.93, p=0.012), and similarly lower in deceased patients compared to survivors (1.85±2.11 vs. 3.79±4.14, p=0.014). Receiver operating characteristic (ROC) curve analysis demonstrated fair discriminatory capacity of the CALLY index for AE-IPF (area under the curve [AUC]: 0.72, cut-off: 0.66, sensitivity: 50.0%, specificity: 85.0%) and mortality (AUC: 0.69, cut-off: 1.19, sensitivity: 58.0%, specificity: 76.0%). The Gender-Age-Physiology (GAP) index showed comparable performance, with AUCs of 0.73 for AE-IPF and 0.75 for mortality, and no significant difference between the two indices (p=0.88 for AE-IPF; p=0.45 for mortality). Among pulmonary function parameters, only diffusing capacity of the lung for carbon monoxide (DLCO%) showed a significant positive correlation with the CALLY index (r=0.265, p=0.0024). CONCLUSIONS: The CALLY index provides an effective method to evaluate functional deterioration and adverse outcomes in IPF patients while serving as a useful predictive instrument. The CALLY index offers a prognostic value similar to the GAP index using standard laboratory tests. Additional prospective validation studies should be conducted.

  • Open Access

    Significance of Plasma Irisin, Adiponectin, and Retinol Binding Protein-4 Levels as Biomarkers for Obstructive Sleep Apnea Syndrome Severity

    by Nevin Fazlıoğlu, Pelin Uysal, Sinem Durmus, Sibel Yurt, Remise Gelisgen, Hafize Uzun

    Objective: Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder that is caused by the reduction or cessation of airflow in the upper airway. Irisin, retinol-binding protein-4 (RBP-4), and adiponectin are the three significant factors in the metabolic process of the human body. The objective of this study was to investigate whether plasma irisin, RBP-4, and adiponectin levels are associated with the severity of OSAS. Methods: According to inclusion and exclusion criteria, 125 patients with OSAS and 46 healthy, gender-matched controls were included in this study. The patients were classified according to the apnea hypopnea index (AHI) as 14 mild cases (5 < AHI < 15), 23 moderate OSAS cases (15 < AHI < 30), and 88 severe OSAS cases (AHI > 30). The plasma irisin, RBP-4, and adiponectin levels were measured and compared between groups. Results: RBP-4 levels were higher in severe OSAS compared to other groups, and irisin levels were significantly lower in severe OSAS compared to other groups. There was a negative correlation between irisin and RBP-4 (r = −0.421; p < 0.001), and irisin and AHI (r = −0.834; p < 0.001), and a positive correlation between irisin and adiponectin (r = 0.240; p = 0.002). There was a negative correlation between RBP-4 and adiponectin (r = −0.507; p < 0.001) and a positive correlation between RBP-4 and AHI (r = 0.473; p < 0.001). As a predictor of OSAS, adiponectin showed the highest specificity (84.8%) and RBP-4 the highest sensitivity (92.0%). Conclusion: Circulating adiponectin, irisin, and RBP-4 may be new biomarkers in OSAS patients in addition to risk factors such as diabetes, obesity, and hypertension. When polysomnography is not available, these parameters and clinical data can be used to diagnose the disease. As a result, patients with an AHI score greater than thirty should be closely monitored for metabolic abnormalities.


  • Open Access

    Significance of Plasma Irisin, Adiponectin and Retinol Binding Protein-4 Levels as Biomarkers for Obstructive Sleep Apnea Syndrome Severity

    by Nevin Fazlıoglu, Pelin Uysal, Sinem Durmuş, Si̇bel Yurt, Remise Gelisgen, Hafize Uzun

    Objective: Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder that is caused by the reduction or cessation of airflow in the upper airway. Irisin, retinol-binding protein-4 (RBP-4), and adiponectin are the three significant factors in the metabolic process of the human body. The objective of this study was to investigate whether plasma irisin, RBP-4, and adiponectin levels are associated with the severity of OSAS. Methods: According to inclusion and exclusion criteria, 125 patients with OSAS and 46 healthy, gender matched controls were included to the study. The patients were classified according to the apnea hypopnea index (AHI) as 14 mild cases (5<AHI<15), 23 moderate OSAS cases (15<AHI30). The plasma irisin, RBP-4 and adiponectin levels were measured and compared between groups. Results: RBP-4 levels were higher in severe OSAS compared to moderate (p<0.05) and mild (p<0.001) OSAS groups, irisin levels were significantly lower compared to moderate (p<0.05) and mild (p<0.001) OSAS groups. There was a negative correlation between irisin and RBP-4 (r=-0.379; p<0.001) and AHI (r=-0.834; p<0.001) and a positive correlation with minimum oxygen saturation (MOS) (r=0.341; p<0.001) in the patient group. In the patient group, there was a negative correlation between adiponectin and BMI (r=-0.682; p<0.001), RBP-4 (r=-0.292; p<0.01) and AHI (r=-0.179; p<0.05) and a positive correlation with MOS (r=0.397; p<0.001). In the patient group, there was a positive correlation between RBP-4 and BMI (r=0.406; p<0.001) and AHI (r=0.473; p<0.001) and a negative correlation with MOS (r=-0.805; p<0.001). As a predictor of OSAS, adiponectin showed the highest specificity (84.8%) and RBP-4 the highest sensitivity (92.0%). Conclusion: The results of the present study demonstrated that the severity of OSAS causes more metabolic problems, including decreased plasma irisin and adiponectin levels and an increased plasma RBP-4 level. As a result, patients with an AHI score greater than thirty should be closely monitored for metabolic and cardiovascular abnormalities.


  • Understanding potential associations between anatomic and other factors in OSA severity

    by Tolga Ersözlü, Mahmut Deniz, Nevin Fazlıoglu, Erdogan Gultekin, Nejat Altintas

    Purpose The aim of this prospective study was to investigate associations between nasal/oropharyngeal structures and a range of factors including age, gender, daytime sleepiness, and body mass index (BMI). Methods Patients with OSA were prospectively selected as research participants in rhinomanometric analysis as well as for otolaryngological evaluation. Participants were grouped as follows according to their apnea/hypopnea index (AHI) scores: no OSA (AHI < 5), mild OSA (5 ≤ AHI ≤ 15), moderate OSA (15 ≤ AHI < 30), and severe OSA (AHI ≥ 30). One-way analysis of variance (ANOVA), Kruskal–Wallis H, and Mann–Whitney U tests were performed to assess OSA severity in terms of the relationships between nasal resistance (NR) and anthropometric indices (body mass index (BMI), Friedman tongue position (FTP)), age, and gender. Results The study cohort of 177 men and 81 women ranged in age between 21 and 76 years, with BMI ranging from 23 to 45. In total, 37 patients were simple snorers (AHI < 5), and 221 patients were diagnosed with OSA. There was no significant difference among the AHI groups in terms of nasal volume (Vol05) (p = 0.952), mean flow (p = 0.778), and mean NR total (p = 0.723). A statistically significant difference was found between the AHI groups in terms of mean BMI and median FTP scores (p < 0.001). Conclusion This study provides evidence that that the oropharyngeal region (oropharynx, tongue, and vallecula) is a more important determinant of OSA severity than the nasal region.


  • Mortality prediction ability of phycians in intensive care units of Turkey (MOPAP)

    by Mehtap Pehlivanlar Küçük, Tevfik Özlü, Ahmet Oğuzhan Küçük, Akın Kaya, Cenk Kıraklı, Özlem Şengören Dikiş, Hale Kefeli Çelik, Serdar Özkan, Hayriye Bektaş Aksoy, Onur Palabıyık, et al.

    Introduction: Intensive care physicians are increasingly involved in decision making about the prognosis of intensive care unit ICU patients. With this study; we aimed to evaluate the power of clinician foresight at prediction of mortality in patient at triage to intensive care and patient follow-up. Materials and Methods: This study was conducted in ICUs located in various geographical regions of Turkey between January 1, 2017-April 30, 2017. The clinical research was planned as observational, multicenter, cross-sectional. Results: A total of 1169 intubated patients were followed in 37 different ICU. At the beginning of the follow-up we asked the physician who will follow the patient in the ICU to give a score for the probability of survival of the patients. Scoring included a total of 6 scores from 0 to 5, with the "0" the worst probability "5" being the best. According to this distribution, only 1 (0.9%) of 113 patients who were given 0 points survived. Three (6.1%) of 49 with the best score of 5 died. Survival rates were significantly different in each score group (r: -0.488; p< 0.001). After the combined mortality estimation scores based on the clinical observations of the physicians (0 and 1 point score was combined as non-survive, 4 and 5 score was combined as survived) 320 of the 545 patients were estimated to be dead and 225 were predicted survival. Sensitivity and spesifity of scoring system to predict mortality was 91.56% (95% Cl: 87.96-94.37), 76.89% (95% CI: 70.82-82.23) respectively. Conclusion: In this study, we concluded that the physicians who follow the patients in the ICU can predict the poor prognosis at the time of admission and the high mortality rate. The physician's opinion on mortality estimation should be considered in intensive care mortality scoring in addition to other laboratory and clinical parameters.


  • Evaluation of plasma LL-37 and nuclear factor kappa B (NF-κB) levels in stable chronic obstructive pulmonary disease

    by Pelin Uysal, Atyac Karadag, Sibel Yurt, Nevin Fazlioglu, Abdulhalim Senyigit, Ramila Hajiyeva, Gonul Simsek, Filiz Kosar, Hafize Uzun

    Background: The main goal of this study was to evaluate the plasma LL-37 and nuclear factor kappa B (NF-κB) levels in stable COPD (chronic obstructive pulmonary disease) patients compared with a control group and to show theirs importance in chronic immune inflammation. Methods: One hundred and thirty-eight stable COPD patients and 33 control subjects were included in the study. The COPD patients were classified into four groups (I/II/II/IV) according to the revised GOLD guidelines, based on the results of spirometry, symptom severity, and history of acute exacerbation reported on the questionnaire. Results: Plasma LL-37 levels were significantly lower while plasma NF-κB levels of the COPD patients were significantly higher than those of the control subjects (p<0.001, in both). Plasma LL-37 levels were significantly lower group IV than group I, II, III (p<0.01, in all). Plasma NF-κB levels were significantly higher group III and IV than group I and III (p<0.05, in both). There was a positive correlation between LL-37 and FEV1 (r=0.194; p=0.022), and FEV1/FVC (r=0.198; p=0.020), while there was a negative correlation with NF-κB (r=-0.271; p=0.001) in all COPD patients. There was a positive correlation between FEV1 and LL-37 (r=0.775; p<0.001), while there was a negative correlation with NF-κB (r=-0.624; p<0.001) in group IV. Conclusions: Our study indicated that plasma LL-37 and NF-κB may play an important role in chronic immune inflammation. Decreased IL-37 levels may be particularly large for patients in stages IV. The role of LL-37 as a target for treatment of immune system and COPD must be widely evaluated.